Protalix BioTherapeutics

$4.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.52 (-11.21%) Today
+$0.02 (+0.49%) As of 12:49 AM UTC after-hours

Why Robinhood?

You can buy or sell PLX and other stocks, options, and ETFs commission-free!

About PLX

Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel. The listed name for PLX is Protalix BioTherapeutics, Inc. Common Stock.

CEO
Dror Bashan
Employees
196
Headquarters
Karmiel, HaZafon
Founded
1993
Market Cap
183.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.98M
High Today
$4.64
Low Today
$3.92
Open Price
$4.62
Volume
1.20M
52 Week High
$7.02
52 Week Low
$2.04

PLX Earnings

-$0.30
-$0.17
-$0.03
$0.10
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

TDF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure